Urease Inhibitory Activity of Tilia rubra subsp. caucasica V.Engl.: Activity-Guided Fractionation of a Folk Medicine
- 1Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Türkiye
- 2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, 06330 Ankara, Türkiye
- 3Department of Bioengineering, İzmir Institute of Technology, 35430 İzmir, Türkiye
Abstract
Bacterial ureases play a key role in the pathogenesis of various diseases, including gastritis, peptic ulcers, urolithiasis, and gastric cancer. Concerns regarding the toxicity and stability of urease inhibitors have prompted the search for safer alternatives from natural sources. Therefore, this study aimed to identify the bioactive compounds responsible for the urease inhibitory activity of Tilia rubra subsp. caucasica V.Engl. [synonym of Tilia dasystyla subsp. caucasica (V.Engl.) Pigott] using activity-guided fractionation. The plant material was subjected to liquid–liquid partitioning followed by chromatographic techniques, with in vitro urease inhibitory activity against jack bean urease evaluated at each step. The structures of the isolated compounds were elucidated by LC-HRMS and NMR spectroscopy. The 80% ethanol extract exhibited notable in vitro urease inhibitory activity (47.14 ± 2.59%). The ethyl acetate subextract was the most active fraction (61.38 ± 0.64% inhibition; IC50 = 71.35 ± 3.48 µg/mL), yielding several compounds, including guaijaverin, trans-tiliroside, isoquercitrin, protocatechuic acid, and a new dimeric flavonoid glycoside (methylenebisastragalin). Guaijaverin (71.86 ± 3.55% inhibition; IC50 = 119.63 ± 3.64 μM) and isoquercitrin (48.04 ± 2.28%) showed the strongest urease inhibitory activity at 100 μg/mL. HPLC quantification showed that guaijaverin and isoquercitrin contribute to the activity of the ethylacetate subextract; however, the compounds responsible for the observed activity could not be fully identified. Molecular docking studies revealed XP GScores of −8.64 and −8.47 kcal/mol for these compounds, respectively. These findings indicate that T. rubra subsp. caucasica is a promising natural source of urease inhibitors, warranting further experimental validation, particularly against bacterial ureases, including that of Helicobacter pylori, to evaluate its therapeutic potential.
Related
- Fractionation, Structural Characterization and In Vitro α-Amylase and α-Glucosidase Inhibitory Activities of Polysaccharides Derived from Lycium barbarum L.
- Phytochemical Profiling, Antioxidant Capacity, and In Vitro α-Amylase/β-Glucosidase Inhibitory Activity of Different Avocado Tissues Under Methanolic and CO2-Assisted Aqueous Extraction
- Integrated Experimental and Computational Investigation of Fluorinated Benzoylthiourea Derivatives: Structural Characterization, Hirshfeld Surface Analysis, Antioxidant Activity, and MAO–B Inhibitory Potential for Parkinson’s Disease
- Design, synthesis, and evaluation of novel hydrazide and hydroxamate derivatives as potent antileukemic agents with preferential HDAC-2 inhibitory activity over class I isoform
- Synthesis, anti-cancer activity, Pim-3 inhibitory potency and zebrafish larvae toxicity evaluation of indolopyrazolocarbazole derivatives
BibTeX
@article{dilmac2026urease,
title = {{Urease Inhibitory Activity of Tilia rubra subsp. caucasica V.Engl.: Activity-Guided Fractionation of a Folk Medicine}},
author = {Elif Dilmaç and İlhan Gürbüz and Gökçen Eren and Erdal Bedir},
journal = {Molecules},
year = {2026},
month = nov,
doi = {10.3390/molecules31213934},
url = {https://www.mdpi.com/1420-3049/31/21/3934},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Urease Inhibitory Activity of Tilia rubra subsp. caucasica V.Engl.: Activity-Guided Fractionation of a Folk Medicine
AU - Elif Dilmaç
AU - İlhan Gürbüz
AU - Gökçen Eren
AU - Erdal Bedir
PY - 2026
DA - 2026/11/01
JO - Molecules
DO - 10.3390/molecules31213934
UR - https://www.mdpi.com/1420-3049/31/21/3934
AB - Bacterial ureases play a key role in the pathogenesis of various diseases, including gastritis, peptic ulcers, urolithiasis, and gastric cancer. Concerns regarding the toxicity and stability of urease inhibitors have prompted the search for safer alternatives from natural sources. Therefore, this study aimed to identify the bioactive compounds responsible for the urease inhibitory activity of Tilia rubra subsp. caucasica V.Engl. [synonym of Tilia dasystyla subsp. caucasica (V.Engl.) Pigott] using activity-guided fractionation. The plant material was subjected to liquid–liquid partitioning followed by chromatographic techniques, with in vitro urease inhibitory activity against jack bean urease evaluated at each step. The structures of the isolated compounds were elucidated by LC-HRMS and NMR spectroscopy. The 80% ethanol extract exhibited notable in vitro urease inhibitory activity (47.14 ± 2.59%). The ethyl acetate subextract was the most active fraction (61.38 ± 0.64% inhibition; IC50 = 71.35 ± 3.48 µg/mL), yielding several compounds, including guaijaverin, trans-tiliroside, isoquercitrin, protocatechuic acid, and a new dimeric flavonoid glycoside (methylenebisastragalin). Guaijaverin (71.86 ± 3.55% inhibition; IC50 = 119.63 ± 3.64 μM) and isoquercitrin (48.04 ± 2.28%) showed the strongest urease inhibitory activity at 100 μg/mL. HPLC quantification showed that guaijaverin and isoquercitrin contribute to the activity of the ethylacetate subextract; however, the compounds responsible for the observed activity could not be fully identified. Molecular docking studies revealed XP GScores of −8.64 and −8.47 kcal/mol for these compounds, respectively. These findings indicate that T. rubra subsp. caucasica is a promising natural source of urease inhibitors, warranting further experimental validation, particularly against bacterial ureases, including that of Helicobacter pylori, to evaluate its therapeutic potential.
SN - 1420-3049
ER -